{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:54:19Z","timestamp":1780354459380,"version":"3.54.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1987,8,1]],"date-time":"1987-08-01T00:00:00Z","timestamp":554774400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Toxicology"],"published-print":{"date-parts":[[1987,8]]},"DOI":"10.1007\/bf03259870","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T10:37:18Z","timestamp":1354185438000},"page":"287-293","source":"Crossref","is-referenced-by-count":24,"title":["Systemic Reactions to Ophthalmic Drug Preparations"],"prefix":"10.1007","volume":"2","author":[{"given":"F. T.","family":"Fraunfelder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Martha","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,27]]},"reference":[{"key":"BF03259870_CR1","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/archinte.1980.00330160136049","volume":"140","author":"SM Abrams","year":"1980","unstructured":"Abrams SM, Degnan TJ, Vinciguerra V. Marrow aplasia following topical application of chloramphenicol eye ointment. Archives of Internal Medicine 140: 576\u2013577, 1980","journal-title":"Archives of Internal Medicine"},{"key":"BF03259870_CR2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-3476(71)80074-4","volume":"79","author":"EW Adcock III","year":"1971","unstructured":"Adcock III EW. Cyclopentolate (Cyclogyl) toxicity in pediatric patients. Journal of Pediatrics 79: 127\u2013129, 1971","journal-title":"Journal of Pediatrics"},{"key":"BF03259870_CR3","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1001\/archinte.1981.00340070032009","volume":"141","author":"AG Adler","year":"1981","unstructured":"Adler AG, McElwain GE, Martin JH. Coronary artery spasm induced by phenylephrine eyedrops. Archives of Internal Medicine 141: 1384\u20131385, 1981","journal-title":"Archives of Internal Medicine"},{"key":"BF03259870_CR4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00003088-198005010-00004","volume":"5","author":"G Alvan","year":"1980","unstructured":"Alvan G, Calissendorff B, Seideman P, Widmark K, Widmark G. Absorption of ocular timolol. Clinical Pharmacokinetics 5: 95\u2013100, 1980","journal-title":"Clinical Pharmacokinetics"},{"key":"BF03259870_CR5","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.1980.03310200015012","volume":"244","author":"K Angelo-Nielsen","year":"1980","unstructured":"Angelo-Nielsen K. Timolol topically and diabetes mellitus. Journal of the American Medical Association 244: 2263, 1980","journal-title":"Journal of the American Medical Association"},{"key":"BF03259870_CR6","first-page":"803","volume":"8","author":"KJ Awan","year":"1976","unstructured":"Awan KJ. Systemic toxicity of cyclopentolate hydrochloride in adults following topical ocular instillation. Annals of Ophthalmology 8: 803\u2013806, 1976","journal-title":"Annals of Ophthalmology"},{"key":"BF03259870_CR7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0022-3476(73)80134-9","volume":"82","author":"CR Bauer","year":"1973","unstructured":"Bauer CR, Trottier MC, Stern L. Systemic cyclopentolate (Cyclogyl) toxicity in the newborn infant. Journal of Pediatrics 82: 501\u2013505, 1973","journal-title":"Journal of Pediatrics"},{"key":"BF03259870_CR8","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0002-9394(62)93421-9","volume":"53","author":"JA Beswick","year":"1962","unstructured":"Beswick JA. Psychosis from cyclopentolate. American Journal of Ophthalmology 53: 879\u2013880, 1962","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259870_CR9","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/0002-9394(63)90196-X","volume":"55","author":"RD Binkhorst","year":"1963","unstructured":"Binkhorst RD, Weinstein GW, Baretz RM, Clahane AC. Psychotic reaction induced by cyclopentolate (Cyclogyl): results of pilot study and a double-blind study. American Journal of Ophthalmology 55: 1243\u20131245, 1963","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259870_CR10","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1542\/peds.51.6.1032","volume":"51","author":"V Borromeo-McGrail","year":"1973","unstructured":"Borromeo-McGrail V, Bordiuk JM, Keitel H. Systemic hypertension following ocular administration of 10% phenylephrine in the neonate. Pediatrics 51: 1032\u20131036, 1973","journal-title":"Pediatrics"},{"key":"BF03259870_CR11","first-page":"1417","volume-title":"Textbook of Medicine","author":"MC Brain","year":"1975","unstructured":"Brain MC. Aplastic anaemia. In Beeson & McDermott (Eds) Textbook of Medicine, 14th ed., pp. 1417\u20131424, W.B. Saunders, Philadelphia, 1975","edition":"14th"},{"key":"BF03259870_CR12","first-page":"566","volume":"300","author":"NA Britman","year":"1979","unstructured":"Britman NA. Cardiac effects of topical timolol. New England Journal of Medicine 300: 566, 1979","journal-title":"New England Journal of Medicine"},{"key":"BF03259870_CR13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(75)92766-X","volume":"2","author":"G Carpenter","year":"1975","unstructured":"Carpenter G. Chloramphenicol eyedrops and marrow aplasia. Lancet 2: 326\u2013327, 1975","journal-title":"Lancet"},{"key":"BF03259870_CR14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archopht.1967.00980030447006","volume":"78","author":"WT Carpenter Jr","year":"1967","unstructured":"Carpenter Jr WT. Precipitous mental deterioration following cycloplegia with 0.2% cyclopentolate HC1. Archives of Ophthalmology 78: 445\u2013447, 1967","journal-title":"Archives of Ophthalmology"},{"key":"BF03259870_CR15","first-page":"1261","volume":"20","author":"E Cass","year":"1979","unstructured":"Cass E, Kadar D, Stein HA. Hazards of phenylephrine topical medication in persons taking propranolol. Canadian Medical Association Journal 20: 1261\u20131262, 1979","journal-title":"Canadian Medical Association Journal"},{"key":"BF03259870_CR16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0002-9394(87)90366-7","volume":"98","author":"JR Coppeto","year":"1984","unstructured":"Coppeto JR. Timolol-associated myasthenia gravis. American Journal of Ophthalmology 98: 244\u2013245, 1984","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259870_CR17","first-page":"64","volume":"17","author":"JR Coppeto","year":"1985","unstructured":"Coppeto JR. Transient ischemic attacks and amaurosis fugax from timolol. Annals of Ophthalmology 17: 64\u201365, 1985","journal-title":"Annals of Ophthalmology"},{"key":"BF03259870_CR18","first-page":"487","volume":"94","author":"SI Davidson","year":"1974","unstructured":"Davidson SI. Systemic effects of eyedrops. Transactions of the Ophthalmological Societies of the United Kingdom 94: 487\u2013494, 1974","journal-title":"Transactions of the Ophthalmological Societies of the United Kingdom"},{"key":"BF03259870_CR19","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/0002-9394(83)90288-X","volume":"95","author":"TE Duncan","year":"1983","unstructured":"Duncan TE. Side effects of topical ocular timolol. American Journal of Ophthalmology 95: 562\u2013563, 1983","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259870_CR20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000309106","volume":"182","author":"V Feiler-Ofry","year":"1981","unstructured":"Feiler-Ofry V, Godel V, Lazar M. Nail pigmentation following timolol maleate therapy. Ophthalmologica 182: 153\u2013156, 1981","journal-title":"Ophthalmologica"},{"key":"BF03259870_CR21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0002-9394(82)90540-2","volume":"93","author":"FT Fraunfelder","year":"1982","unstructured":"Fraunfelder FT, Bagby Jr GC, Kelly DJ. Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol. American Journal of Ophthalmology 93: 356\u2013360, 1982","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259870_CR22","first-page":"1441","volume":"311","author":"FT Fraunfelder","year":"1984","unstructured":"Fraunfelder FT, Barker AF. Respiratory effects of timolol. New England Journal of Medicine 311: 1441, 1984","journal-title":"New England Journal of Medicine"},{"key":"BF03259870_CR23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0002-9394(85)90371-X","volume":"99","author":"FT Fraunfelder","year":"1985","unstructured":"Fraunfelder FT, Meyer SM. Possible cardiovascular effects secondary to topical ophthalmic 2.5% phenylephrine. American Journal of Ophthalmology 99: 362\u2013363, 1985a","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259870_CR24","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1001\/jama.1985.03350450064016","volume":"253","author":"FT Fraunfelder","year":"1985","unstructured":"Fraunfelder FT, Meyer SM. Sexual dysfunction secondary to topical ophthalmic timolol. Journal of the American Medical Association 253: 3092\u20133093, 1985b","journal-title":"Journal of the American Medical Association"},{"key":"BF03259870_CR25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0002-9394(14)75239-0","volume":"85","author":"FT Fraunfelder","year":"1978","unstructured":"Fraunfelder FT, Scafidi AE. Possible adverse effects from topical ocular 10% phenylephrine. American Journal of Ophthalmology 85: 447\u2013453, 1978","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259870_CR26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archopht.1936.00840230119009","volume":"16","author":"P Heath","year":"1936","unstructured":"Heath P. Neosynephrin hydrochloride: some uses and effects in ophthalmology. Archives of Ophthalmology 16: 839\u2013846, 1936","journal-title":"Archives of Ophthalmology"},{"key":"BF03259870_CR27","first-page":"367","volume":"139","author":"MC Hermansen","year":"1985","unstructured":"Hermansen MC, Sullivan LS. Feeding intolerance following ophthalmologic examination. American Journal of Diseases of Children 139: 367\u2013368, 1985","journal-title":"American Journal of Diseases of Children"},{"key":"BF03259870_CR28","first-page":"100","volume":"175","author":"H Huismans","year":"1979","unstructured":"Huismans H. Acute psychosis after cyclopentolate HCC. Klinische Monatsblatter f\u00fcr Augenheilkunde 175: 100, 1979","journal-title":"Klinische Monatsblatter f\u00fcr Augenheilkunde"},{"key":"BF03259870_CR29","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0161-6420(85)33979-9","volume":"92","author":"SJ Isenberg","year":"1985","unstructured":"Isenberg SJ, Abrams C, Hyman PE. Effects of cyclopentolate eyedrops on gastric secretory function in pre-term infants. Ophthalmology 92: 698\u2013700, 1985","journal-title":"Ophthalmology"},{"key":"BF03259870_CR30","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1001\/jama.1980.03310240022015","volume":"244","author":"FL Jones Jr","year":"1980","unstructured":"Jones Jr FL, Ekberg NL. Exacerbation of obstructive airway disease by timolol. Journal of the American Medical Association 244: 2730, 1980","journal-title":"Journal of the American Medical Association"},{"key":"BF03259870_CR31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/jop.1985.1.79","volume":"1","author":"T Kaila","year":"1985","unstructured":"Kaila T, Salminen L, Huupponen R. Systemic absorption of topically applied ocular timolol. Journal of Ocular Pharmacology 1: 79\u201383, 1985","journal-title":"Journal of Ocular Pharmacology"},{"key":"BF03259870_CR32","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/archopht.1972.01000020636004","volume":"87","author":"JS Kennerdell","year":"1972","unstructured":"Kennerdell JS, Wucher FP. Cyclopentolate associated with two cases of grand mal seizure. Archives of Ophthalmology 87: 634\u2013635, 1972","journal-title":"Archives of Ophthalmology"},{"key":"BF03259870_CR33","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0002-9394(14)78119-X","volume":"85","author":"JM Kim","year":"1978","unstructured":"Kim JM, Stevenson CE, Mathewson HS. Hypertensive reactions to phenylephrine eyedrops in patients with sympathetic denervation. American Journal of Ophthalmology 85: 862\u2013868, 1978","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259870_CR34","first-page":"131","volume":"7","author":"V Kumar","year":"1985","unstructured":"Kumar V, Packer AJ, Choi WW. Hypertension following phenylephrine 2.5% ophthalmic drops. Glaucoma 7: 131\u2013132, 1985a","journal-title":"Glaucoma"},{"key":"BF03259870_CR35","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0002-9394(85)90229-6","volume":"99","author":"V Kumar","year":"1985","unstructured":"Kumar V, Schoenwald RD, Chien DS, Packer AJ, Choi WW. Systemic absorption and cardiovascular effects of phenylephrine eyedrops. American Journal of Ophthalmology 99: 180\u2013184, 1985b","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259870_CR36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0002-9394(66)90752-5","volume":"61","author":"RK Lansche","year":"1966","unstructured":"Lansche RK. Systemic reactions to topical epinephrine and phenylephrine. American Journal of Ophthalmology 61: 95, 1966","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259870_CR37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1542\/peds.68.2.231","volume":"68","author":"BJ Lees","year":"1981","unstructured":"Lees BJ, Cabal LA. Increased blood pressure following pupillary dilation with 2.5% phenylephrine hydrochloride in preterm infants. Pediatrics 68: 231\u2013234, 1981","journal-title":"Pediatrics"},{"key":"BF03259870_CR38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2125.1985.tb02651.x","volume":"19","author":"RV Lewis","year":"1985","unstructured":"Lewis RV, Lennard MS, Jackson PR, Tucker GT, Ramsay LE, et al. Timolol and atenolol: relationships between oxidation phenotype, pharmacokinetics and pharmacodynamics. British Journal of Clinical Pharmacology 19: 329\u2013333, 1985","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259870_CR39","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(77)90765-6","volume":"2","author":"TG Matthews","year":"1977","unstructured":"Matthews TG, Wilczek AM, Shenan AT. Eye-drop induced hypertension. Lancet 2: 827, 1977","journal-title":"Lancet"},{"key":"BF03259870_CR40","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/archopht.1956.00930040184003","volume":"56","author":"WV McReynolds","year":"1956","unstructured":"McReynolds WV, Havener WH, Henderson JW. Hazards in the use of sympathomimetic drugs in ophthalmology. Archives of Ophthalmology 56: 176\u2013179, 1956","journal-title":"Archives of Ophthalmology"},{"key":"BF03259870_CR41","first-page":"291","volume":"13","author":"SA Miller","year":"1978","unstructured":"Miller SA, Mieler WF. Systemic reaction to subconjunctival phenylephrine. Canadian Journal of Ophthalmology 13: 291\u2013293, 1978","journal-title":"Canadian Journal of Ophthalmology"},{"key":"BF03259870_CR42","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/0002-9394(86)90532-5","volume":"102","author":"WL Nelson","year":"1986","unstructured":"Nelson WL, Fraunfelder FT, Sills JM, Arrowsmith JB, Kuritsky JN. Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978\u20131985. American Journal of Ophthalmology, 102: 606\u2013611, 1986","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259870_CR43","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1001\/jama.1982.03320360019022","volume":"247","author":"BT Nolan","year":"1982","unstructured":"Nolan BT. Acute suicidal depression associated with use of timolol. Journal of the American Medical Association 247: 1567, 1982","journal-title":"Journal of the American Medical Association"},{"key":"BF03259870_CR44","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0161-6420(84)34141-0","volume":"91","author":"MS Passo","year":"1984","unstructured":"Passo MS, Palmer EA, Van Buskirk EM. Plasma timolol in glaucoma patients. Ophthalmology 91: 1361\u20131363, 1984","journal-title":"Ophthalmology"},{"key":"BF03259870_CR45","first-page":"31","volume":"18","author":"BCP Polak","year":"1984","unstructured":"Polak BCP. Chloramphenicol in ophthalmology. Geneesmiddelenbulletin 18: 31\u201332, 1984","journal-title":"Geneesmiddelenbulletin"},{"key":"BF03259870_CR46","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/0002-9394(64)90021-2","volume":"58","author":"DL Praeger","year":"1964","unstructured":"Praeger DL, Miller SN. Toxic effects of cyclopentolate (Cyclogel): report of a case. American Journal of Ophthalmology 58: 1060\u20131061, 1964","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259870_CR47","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/bmj.294.6565.155-a","volume":"294","author":"SD Pringle","year":"1987","unstructured":"Pringle SD, MacEwen CJ. Severe bradycardia due to interaction of timolol eye drops and verapmil. British Medical Journal 294: 155\u2013156, 1987","journal-title":"British Medical Journal"},{"key":"BF03259870_CR48","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0002-9394(79)90361-1","volume":"87","author":"D Robertson","year":"1979","unstructured":"Robertson D. Contraindication of the use of ocular phenylephrine in idiopathic orthostatic hypotension. American Journal of Ophthalmology 87: 819\u2013822, 1979","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259870_CR49","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3928\/0191-3913-19811101-11","volume":"18","author":"T Rosales","year":"1981","unstructured":"Rosales T, Isenberg S, Leake R, Everett S. Systemic effects of mydriatics in low weight infants. Journal of Pediatric Ophthalmology and Strabismus 18: 42\u201344, 1981","journal-title":"Journal of Pediatric Ophthalmology and Strabismus"},{"key":"BF03259870_CR50","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jama.1965.03080020064025","volume":"191","author":"RL Rosenthal","year":"1965","unstructured":"Rosenthal RL, Blackman A. Bone marrow hypoplasia following use of chloramphenicol eye drops. Journal of the American Medical Association 191: 136\u2013137, 1965","journal-title":"Journal of the American Medical Association"},{"key":"BF03259870_CR51","first-page":"16","volume":"23","author":"S Samantary","year":"1975","unstructured":"Samantary S, Thomas A. Systemic effects of topical phenylephrine. Indian Journal of Ophthalmology 23: 16\u201317, 1975","journal-title":"Indian Journal of Ophthalmology"},{"key":"BF03259870_CR52","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1001\/jama.1979.03300150017011","volume":"242","author":"SA Shaivitz","year":"1979","unstructured":"Shaivitz SA. Timolol and myasthenia gravis. Journal of the American Medical Association 242: 1611\u20131612, 1979","journal-title":"Journal of the American Medical Association"},{"key":"BF03259870_CR53","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000309057","volume":"181","author":"ZM Shihab","year":"1980","unstructured":"Shihab ZM. Psychotic reaction in an adult after topical cyclopentolate. Ophthalmologica 181: 228\u2013230, 1980","journal-title":"Ophthalmologica"},{"key":"BF03259870_CR54","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1001\/archopht.1962.00960020408005","volume":"67","author":"CW Simcoe","year":"1962","unstructured":"Simcoe CW. Cyclopentolate (Cyclogyl) toxicity: report of a case. Archives of Ophthalmology 67: 406\u2013408, 1962","journal-title":"Archives of Ophthalmology"},{"key":"BF03259870_CR55","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00000542-197202000-00026","volume":"36","author":"D Solosko","year":"1972","unstructured":"Solosko D, Smith RB. Hypertension following 10 per cent phenylephrine ophthalmic. Anesthesiology 36: 187\u2013189, 1972","journal-title":"Anesthesiology"},{"key":"BF03259870_CR56","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1001\/archinte.1986.00360180240037","volume":"146","author":"ER Swenson","year":"1986","unstructured":"Swenson ER. Severe hyperkalemia as a complication of timolol, a topically applied \u03b2-adrenergic antagonist. Archives of Internal Medicine 146: 1220\u20131223, 1986","journal-title":"Archives of Internal Medicine"},{"key":"BF03259870_CR57","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0161-6420(80)35215-9","volume":"87","author":"EM Buskirk Van","year":"1980","unstructured":"Van Buskirk EM. Adverse reactions from timolol administration. Ophthalmology 87: 447\u2013450, 1980","journal-title":"Ophthalmology"},{"key":"BF03259870_CR58","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/archopht.1981.03930010696022","volume":"99","author":"EM Buskirk Van","year":"1981","unstructured":"Van Buskirk EM, Fraunfelder FT. Timolol and glaucoma. Archives of Ophthalmology 99: 696, 1981","journal-title":"Archives of Ophthalmology"},{"key":"BF03259870_CR59","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0002-9394(84)90250-2","volume":"98","author":"EM Buskirk Van","year":"1984","unstructured":"Van Buskirk EM, Fraunfelder FT. Ocular \u03b2 blockers and systemic effects. American Journal of Ophthalmology 98: 623\u2013624, 1984","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259870_CR60","first-page":"161","volume":"52","author":"RW Vaughan","year":"1973","unstructured":"Vaughan RW. Ventricular arrhythmias after topical vasoconstrictors. Anesthesia and Analgesia 52: 161\u2013165, 1973","journal-title":"Anesthesia and Analgesia"},{"key":"BF03259870_CR61","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/archinte.1983.00350080149037","volume":"143","author":"TM Velde","year":"1983","unstructured":"Velde TM, Kaiser FE. Ophthalmic timolol treatment causing altered hypoglycemic response in a diabetic patient. Archives of Internal Medicine 143: 1627, 1983","journal-title":"Archives of Internal Medicine"},{"key":"BF03259870_CR62","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ana.410170222","volume":"17","author":"A Verkijk","year":"1985","unstructured":"Verkijk A. Worsening of myasthenia gravis with timolol maleate eyedrops. Annals of Neurology 17: 211\u2013212, 1985","journal-title":"Annals of Neurology"},{"key":"BF03259870_CR63","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0002-9394(82)90545-1","volume":"93","author":"M Wellwood","year":"1982","unstructured":"Wellwood M, Goresky GV. Systemic hypertension associated with topical administration of 2.5% phenylephrine HCI. American Journal of Ophthalmology 93: 369\u2013370, 1982","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259870_CR64","first-page":"311","volume":"13","author":"RE Wesley","year":"1981","unstructured":"Wesley RE, Blount WC, Arterberry JF. Pulmonary embolism in a diabetic patient after ocular 10% phenylephrine. Annals of Ophthalmology 13: 311\u2013313, 1981","journal-title":"Annals of Ophthalmology"},{"key":"BF03259870_CR65","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0002-9394(73)90023-8","volume":"76","author":"JT Wilensky","year":"1973","unstructured":"Wilensky JT, Woodward HJ. Acute systemic hypertension after conjunctival instillation of phenylephrine hydrochloride. American Journal of Ophthalmology 76: 156\u2013157, 1973","journal-title":"American Journal of Ophthalmology"},{"key":"BF03259870_CR66","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jama.1980.03310080010007","volume":"244","author":"D Yates","year":"1980","unstructured":"Yates D. Syncope and visual hallucinations, apparently from timolol. Correspondence. Journal of the American Medical Association 244: 768\u2013769, 1980","journal-title":"Correspondence. Journal of the American Medical Association"},{"key":"BF03259870_CR67","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/archopht.1984.01040030429017","volume":"102","author":"TJ Zimmerman","year":"1984","unstructured":"Zimmerman TJ, Kooner KS, Kanderakis AS, Ziegler LP. Improving the therapeutic index of topically applied ocular drugs. Archives of Ophthalmology 102: 551\u2013553, 1984","journal-title":"Archives of Ophthalmology"}],"container-title":["Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259870.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03259870\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259870","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T14:45:36Z","timestamp":1643726736000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03259870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,8]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1987,8]]}},"alternative-id":["BF03259870"],"URL":"https:\/\/doi.org\/10.1007\/bf03259870","relation":{},"ISSN":["0112-5966"],"issn-type":[{"value":"0112-5966","type":"print"}],"subject":[],"published":{"date-parts":[[1987,8]]}}}